IP for the PI

What is intellectual property?It's any product of the human mind that has commercial value. This can include literary works or a concept for a new tool; for life scientists, this may mean a lab technique or a new small molecule. The courts protect intellectual property with patents and copyrights.If I'm listed as the inventor on a patent, does that mean I own it?No, in most cases the inventor's institution – be it a private company, university, or government-run organization – keeps

Written byMaria Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

It's any product of the human mind that has commercial value. This can include literary works or a concept for a new tool; for life scientists, this may mean a lab technique or a new small molecule. The courts protect intellectual property with patents and copyrights.

No, in most cases the inventor's institution – be it a private company, university, or government-run organization – keeps the rights, since it pays the filing and attorney fees. However, if an institution has no plans to capitalize on a patent, a researcher might be able to buy it back.

Most individual scientists don't have the time, money, or expertise to write a patent application, afford the filing fees (usually between $5,000–$7,000), and secure a licensing agreement. Institutions' tech transfer offices (TTOs) make these things happen: they split the patent's proceeds or royalties with the inventor and the academic department, usually not lots of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies